Effect of The Receptor Activator of Nuclear Factor кB and RANK Ligand on In Vitro Differentiation of Cord Blood CD133(+) Hematopoietic Stem Cells to Osteoclasts

OBJECTIVE: Receptor activator of nuclear factor-kappa B ligand (RANKL) appears to be an osteoclast-activating factor, bearing an important role in the pathogenesis of multiple myeloma. Some studies demonstrated that U-266 myeloma cell line and primary myeloma cells expressed RANK and RANKL. It had b...

Descripción completa

Detalles Bibliográficos
Autores principales: Kalantari, Nasim, Abroun, Saeid, Soleimani, Masoud, Kaviani, Saeid, Azad, Mehdi, Eskandari, Fatemeh, Habibi, Hossein
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Royan Institute 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5011319/
https://www.ncbi.nlm.nih.gov/pubmed/27602313

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5011319/
https://www.ncbi.nlm.nih.gov/pubmed/27602313

Ejemplares similares